AstraZeneca PLC (AZN) Gains After Successful Saphnelo Trial
On the same day, AstraZeneca announced statistically significant results from its Phase III TULIP‑SC trial of Saphnelo (anifrolumab) in systemic lupus erythematosus (SLE).
Astrazeneca Plc (AZN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sivik Global Healthcare Krishen Sud | 40,000 | $3,677 | 1.07% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,628,771 | $149,146,561 | 0.24% | |
| 2. | 841,574 | $77,365,898 | 0.12% | |
| 3. | 787,084 | $72,356,632 | 0.1% | |
| 4. | 763,309 | $70,170,968 | 2.53% | |
| 5. | 562,431 | $51,704,280 | 3.66% |
News See All
Top 10 Oncology Stocks to Buy Now
The oncology market in the United States was estimated at $81.34 billion in 2025 and is expected to reach $211.78 billion by 2034 with a compound annual growth rate of 11.75%.
AstraZeneca’s Subcutaneous Saphnelo Shows Significant Disease Reduction in Landmark Lupus Trial
AstraZeneca (NASDAQ:AZN) is one of the best future stocks to buy for the long term.
12 Best Future Stocks to Buy For the Long Term
On January 6, Dan Ives of Wedbush Securities joined 'Closing Bell' on CNBC to suggest that the tech bull market continues to play out.
What Makes AstraZeneca (AZN) a Strong Growing Company?
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 investor letter.
Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) - Here's Why
AstraZeneca PLC (NASDAQ:AZN) is one of the best performing pharma stocks in 2025. On January 7, Berenberg Bank reiterated a Buy rating on AstraZeneca PLC (NASDAQ:AZN) with a price target of $95.
10 Best Performing Pharma Stocks in 2025
On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss his bullish outlook on biopharma stocks in 2026 and the pharma M&A outlook...
10 Best Non-US Stocks to Buy According to Hedge Funds
On December 9, Michelle Gibley, Director of International Equity Research and Strategy at the Schwab Center for Financial Research, released her 2026 Outlook for International Stocks and Economy.
AstraZeneca (AZN) At the Center of Serious Analyst Attention
AstraZeneca PLC (NASDAQ:AZN), the British pharmaceutical company best known for its COVID-19 drug, was at the center of analyst action on December 9th after a report from TD Cowen.
13 Best ADR Stocks to Invest In
ADRs, or American Depository Receipts, are the US-listed securities of foreign firms that allow investors in America to buy and trade the shares within America.